Autism Spectrum Disorders Market 2027 by Type, Treatment Type and Geography | The Insight Partners

Autism Spectrum Disorders Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Autistic Disorder, Pervasive Developmental Disorder, Asperger syndrome, Others); Treatment Type (Drug Therapy, Communication and Behavioral Therapy) and Geography

Report Code: TIPRE00008010 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Autism Spectrum Disorder (ASD) is a group of neurological conditions, which hampers developmental of social interaction, communication and use of verbal and non-verbal language. The exact cause is still unknown. People with autism have issues in carrying out regular activities. Children with autism have issues during social interaction. Social interaction and communication are the core impairments of ASD, whereas, seizures, sensory issues, anxiety, sleep deficits, self-injury and others are associated symptoms. There is no definitive treatment for the treatment of core symptoms yet, however, the FDA have approved many drugs for associated symptoms. For instance, antipsychotics such as risperidone and aripripazole are used in treating irritability associated with disorder.

MARKET DYNAMICS

The autism spectrum disorders market is anticipated to grow in the forecast period owing to the increasing research and development for discovery of novel therapies. Growing pipeline for the autism spectrum disorder is one of the prime factors for the growth of the market. There is no current therapies for the treatment of autism spectrum disorders, which have increased number of untreated population. For instance, autism prevalence has increased by 15% in children, affecting 1 out of 59 children, the CDC. Moreover, increasing government efforts to increasing knowledge regarding autism is boosting the growth of the market. For instance, in August 2019, the Centers for Disease Control and Prevention announced to invest USD 27 million in the next five years to conduct the Study to Explore Early Development (SEED). This is one of the largest studies in the U.S., which will help in identifying risk factors in children for autism spectrum disorder (ASD).

MARKET SCOPE

The "Global Autism Spectrum Disorders Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of autism spectrum disorders market with detailed market segmentation by type, treatment type and geography. The global autism spectrum disorders market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading autism spectrum disorders market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global autism spectrum disorders market is segmented on the basis of type, and treatment type. Based on type, the market is segmented as autistic disorder, pervasive developmental disorder, Asperger syndrome and others. Based on treatment type, the market is segmented as drug therapy and communication & behavioral therapy.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Autism Spectrum Disorders market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The autism spectrum disorders market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting autism spectrum disorders market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the autism spectrum disorders market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the autism spectrum disorders market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from autism spectrum disorders market are anticipated to lucrative growth opportunities in the future with the rising demand for autism spectrum disorders market in the global market. Below mentioned is the list of few companies engaged in the autism spectrum disorders market.

The report also includes the profiles of key autism spectrum disorders market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  F. Hoffmann-La Roche AG
  •  Nobelpharma Co., Ltd.
  •  Johnson & Johnson
  •  Yamo Pharmaceuticals
  •  Curemark
  •  Servier
  •  Neurochlore

Pipeline Analysis

Many companies are engaged in the development of autism spectrum disorders drugs, which are currently in the pipeline. Some of the major brands are F. Hoffmann-La Roche AG, Nobelpharma Co., Ltd., Johnson & Johnson, Yamo Pharmaceuticals, Curemark, Servier, Neurochlore among others.
Some of the major pipeline drugs are mentioned below:
- In 2018, Roche's received breakthrough therapy designation for balovaptan in autism spectrum disorder from the FDA. Balovaptan is expected to be first pharmacotherapy, which will help in improving core social interaction and communication in patients
- In 2018, Yamo Pharmaceuticals, LLC, received Fast Track Designation for L1-79, which is a tyrosine hydroxylase inhibitor. This will help in reducing the socialization and communication symptoms in patients suffering with autism spectrum disorder (ASD)
- In May 2019, Finch Therapeutics received fast track designation by the FDA for its Full-Spectrum Microbiota, or FSM therapy for children with autism spectrum disorder
- In June 2019, Q BioMed Inc., which is commercial stage biotech company, filed for Orphan Drug designation for QBM-001. This product is being designed to treat pediatric minimally verbal autism (PVMA)

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Autism Spectrum Disorders Market - By Type
1.3.2 Autism Spectrum Disorders Market - By Treatment Type
1.3.3 Autism Spectrum Disorders Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. AUTISM SPECTRUM DISORDERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AUTISM SPECTRUM DISORDERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. AUTISM SPECTRUM DISORDERS MARKET - GLOBAL MARKET ANALYSIS
6.1. AUTISM SPECTRUM DISORDERS - GLOBAL MARKET OVERVIEW
6.2. AUTISM SPECTRUM DISORDERS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. AUTISM SPECTRUM DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. AUTISTIC DISORDER
7.3.1. Overview
7.3.2. Autistic Disorder Market Forecast and Analysis
7.4. PERVASIVE DEVELOPMENTAL DISORDER
7.4.1. Overview
7.4.2. Pervasive Developmental Disorder Market Forecast and Analysis
7.5. ASPERGER SYNDROME
7.5.1. Overview
7.5.2. Asperger syndrome Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. AUTISM SPECTRUM DISORDERS MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. DRUG THERAPY
8.3.1. Overview
8.3.2. Drug Therapy Market Forecast and Analysis
8.4. COMMUNICATION AND BEHAVIORAL THERAPY
8.4.1. Overview
8.4.2. Communication and Behavioral Therapy Market Forecast and Analysis
9. AUTISM SPECTRUM DISORDERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Autism Spectrum Disorders Market Overview
9.1.2 North America Autism Spectrum Disorders Market Forecasts and Analysis
9.1.3 North America Autism Spectrum Disorders Market Forecasts and Analysis - By Type
9.1.4 North America Autism Spectrum Disorders Market Forecasts and Analysis - By Treatment Type
9.1.5 North America Autism Spectrum Disorders Market Forecasts and Analysis - By Countries
9.1.5.1 United States Autism Spectrum Disorders Market
9.1.5.1.1 United States Autism Spectrum Disorders Market by Type
9.1.5.1.2 United States Autism Spectrum Disorders Market by Treatment Type
9.1.5.2 Canada Autism Spectrum Disorders Market
9.1.5.2.1 Canada Autism Spectrum Disorders Market by Type
9.1.5.2.2 Canada Autism Spectrum Disorders Market by Treatment Type
9.1.5.3 Mexico Autism Spectrum Disorders Market
9.1.5.3.1 Mexico Autism Spectrum Disorders Market by Type
9.1.5.3.2 Mexico Autism Spectrum Disorders Market by Treatment Type
9.2. EUROPE
9.2.1 Europe Autism Spectrum Disorders Market Overview
9.2.2 Europe Autism Spectrum Disorders Market Forecasts and Analysis
9.2.3 Europe Autism Spectrum Disorders Market Forecasts and Analysis - By Type
9.2.4 Europe Autism Spectrum Disorders Market Forecasts and Analysis - By Treatment Type
9.2.5 Europe Autism Spectrum Disorders Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Autism Spectrum Disorders Market
9.2.5.1.1 Germany Autism Spectrum Disorders Market by Type
9.2.5.1.2 Germany Autism Spectrum Disorders Market by Treatment Type
9.2.5.2 France Autism Spectrum Disorders Market
9.2.5.2.1 France Autism Spectrum Disorders Market by Type
9.2.5.2.2 France Autism Spectrum Disorders Market by Treatment Type
9.2.5.3 Italy Autism Spectrum Disorders Market
9.2.5.3.1 Italy Autism Spectrum Disorders Market by Type
9.2.5.3.2 Italy Autism Spectrum Disorders Market by Treatment Type
9.2.5.4 Spain Autism Spectrum Disorders Market
9.2.5.4.1 Spain Autism Spectrum Disorders Market by Type
9.2.5.4.2 Spain Autism Spectrum Disorders Market by Treatment Type
9.2.5.5 United Kingdom Autism Spectrum Disorders Market
9.2.5.5.1 United Kingdom Autism Spectrum Disorders Market by Type
9.2.5.5.2 United Kingdom Autism Spectrum Disorders Market by Treatment Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Autism Spectrum Disorders Market Overview
9.3.2 Asia-Pacific Autism Spectrum Disorders Market Forecasts and Analysis
9.3.3 Asia-Pacific Autism Spectrum Disorders Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Autism Spectrum Disorders Market Forecasts and Analysis - By Treatment Type
9.3.5 Asia-Pacific Autism Spectrum Disorders Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Autism Spectrum Disorders Market
9.3.5.1.1 Australia Autism Spectrum Disorders Market by Type
9.3.5.1.2 Australia Autism Spectrum Disorders Market by Treatment Type
9.3.5.2 China Autism Spectrum Disorders Market
9.3.5.2.1 China Autism Spectrum Disorders Market by Type
9.3.5.2.2 China Autism Spectrum Disorders Market by Treatment Type
9.3.5.3 India Autism Spectrum Disorders Market
9.3.5.3.1 India Autism Spectrum Disorders Market by Type
9.3.5.3.2 India Autism Spectrum Disorders Market by Treatment Type
9.3.5.4 Japan Autism Spectrum Disorders Market
9.3.5.4.1 Japan Autism Spectrum Disorders Market by Type
9.3.5.4.2 Japan Autism Spectrum Disorders Market by Treatment Type
9.3.5.5 South Korea Autism Spectrum Disorders Market
9.3.5.5.1 South Korea Autism Spectrum Disorders Market by Type
9.3.5.5.2 South Korea Autism Spectrum Disorders Market by Treatment Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Autism Spectrum Disorders Market Overview
9.4.2 Middle East and Africa Autism Spectrum Disorders Market Forecasts and Analysis
9.4.3 Middle East and Africa Autism Spectrum Disorders Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Autism Spectrum Disorders Market Forecasts and Analysis - By Treatment Type
9.4.5 Middle East and Africa Autism Spectrum Disorders Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Autism Spectrum Disorders Market
9.4.5.1.1 South Africa Autism Spectrum Disorders Market by Type
9.4.5.1.2 South Africa Autism Spectrum Disorders Market by Treatment Type
9.4.5.2 Saudi Arabia Autism Spectrum Disorders Market
9.4.5.2.1 Saudi Arabia Autism Spectrum Disorders Market by Type
9.4.5.2.2 Saudi Arabia Autism Spectrum Disorders Market by Treatment Type
9.4.5.3 U.A.E Autism Spectrum Disorders Market
9.4.5.3.1 U.A.E Autism Spectrum Disorders Market by Type
9.4.5.3.2 U.A.E Autism Spectrum Disorders Market by Treatment Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Autism Spectrum Disorders Market Overview
9.5.2 South and Central America Autism Spectrum Disorders Market Forecasts and Analysis
9.5.3 South and Central America Autism Spectrum Disorders Market Forecasts and Analysis - By Type
9.5.4 South and Central America Autism Spectrum Disorders Market Forecasts and Analysis - By Treatment Type
9.5.5 South and Central America Autism Spectrum Disorders Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Autism Spectrum Disorders Market
9.5.5.1.1 Brazil Autism Spectrum Disorders Market by Type
9.5.5.1.2 Brazil Autism Spectrum Disorders Market by Treatment Type
9.5.5.2 Argentina Autism Spectrum Disorders Market
9.5.5.2.1 Argentina Autism Spectrum Disorders Market by Type
9.5.5.2.2 Argentina Autism Spectrum Disorders Market by Treatment Type
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. AUTISM SPECTRUM DISORDERS MARKET, KEY COMPANY PROFILES
11.1. F. HOFFMANN-LA ROCHE AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. NOBELPHARMA CO., LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. JOHNSON & JOHNSON
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. YAMO PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CUREMARK
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SERVIER
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NEUROCHLORE
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. F. Hoffmann-La Roche AG
2. Nobelpharma Co., Ltd.
3. Johnson & Johnson
4. Yamo Pharmaceuticals
5. Curemark
6. Servier
7. Neurochlore
TIPRE00008010
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking